Síndrome de Sjögren

Foulks GN, Forstot SL, Donshik PC, et al. The Sjogren's Syndrome Foundation clinical practice guidelines. Ocular management in Sjogren's patients. 2015 [internet publication].Texto completo

Vivino FB, Zero D, Brennan M, et al. Sjogren's Syndrome Foundation's clinical practice guidelines. Oral management: caries prevention in Sjogren's patients. 2015 [internet publication].Texto completo

Carsons SE, Vivino FB, Parke A, et al. Treatment guidelines for rheumatologic manifestations of Sjögren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain. Arthritis Care Res (Hoboken). 2017 Apr;69(4):517-27.Texto completo  Resumo

1. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013 Sep;9(9):544-56. Resumo

2. Fox PC. Autoimmune diseases and Sjogren's syndrome, an autoimmune exocrinopathy. Ann N Y Acad Sci. 2007 Mar;1098:15-21. Resumo

3. Anaya JM, Tobon GJ, Vega P, et al. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J Rheumatol. 2006 Nov;33(11):2227-34. Resumo

4. Steinberg AD, Talal N. The coexistence of Sjogren's syndrome and systemic lupus erythematosus. Ann Intern Med. 1971 Jan;74(1):55-61. Resumo

5. Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979 May;66(5):733-6. Resumo

6. Foster H, Fay A, Kelly C, et al. Thyroid disease and other autoimmune phenomena in a family study of primary Sjogren's syndrome. Br J Rheumatol. 1993 Jan;32(1):36-40. Resumo

7. Alarcon-Segovia D, Ibanez G, Hernandez-Ortiz J, et al. Sjogren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med. 1974 Jul;57(1):78-85. Resumo

8. Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015 Nov;74(11):1983-9. Resumo

9. Alani H, Henty JR, Thompson NL, et al. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018 Mar;47(2):141-54. Resumo

10. Brito-Zerón P, Acar-Denizli N, Zeher M, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2017 Jun;76(6):1042-50. Resumo

11. Fox RI. Sjogren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31. Resumo

12. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren's syndrome. Nat Clin Pract Rheumatol. 2006 May;2(5):252-61. Resumo

13. Maciel G, Crowson CS, Matteson EL, et al. Incidence and mortality of physician-diagnosed primary Sjögren syndrome: time trends over a 40-year period in a population-based US cohort. Mayo Clin Proc. 2017 May;92(5):734-43. Resumo

14. Baldini C, Mosca M, Della Rossa A, et al. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol. 2013 Mar-Apr;31(2):272-80. Resumo

15. Salliot C, Mouthon L, Ardizzone M, et al. Sjogren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford). 2007 Feb;46(2):321-6.Texto completo  Resumo

16. Nordmark G, Alm GV, Ronnblom L. Mechanisms of disease: primary Sjogren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol. 2006 May;2(5):262-9. Resumo

17. Gottenberg JE, Busson M, Loiseau P, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 2003 Aug;48(8):2240-5. Resumo

18. Scofield RH. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol. 2009 Sep;21(5):448-53. Resumo

19. Nagata Y, Inoue H, Yamada K, et al. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients. Immunology. 2004 Feb;111(2):223-9.Texto completo  Resumo

20. Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren's syndrome. Transl Res. 2006 Dec;148(6):281-8. Resumo

21. Scheinfeld N. Sjogren syndrome and systemic lupus erythematosus are distinct conditions. Dermatol Online J. 2006 Jan 27;12(1):4.Texto completo  Resumo

22. Hammi AR, Al-Hashimi IH, Nunn ME, et al. Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren's syndrome. J Oral Pathol Med. 2005 Apr;34(4):198-203. Resumo

23. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjogren's syndrome. Am J Ophthalmol. 2005 Nov;140(5):898-9. Resumo

24. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001 Sep;2(9):777-80. Resumo

25. Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol. 2006 Mar;142(3):371-6. Resumo

26. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient? J Rheumatol. 2003 Nov;30(11):2413-9. Resumo

27. Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome. Eur J Oral Sci. 2005 Apr;113(2):101-13. Resumo

28. Liu K, Kurien BT, Zimmerman SL, et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheumatol. 2016 May;68(5):1290-1300.Texto completo  Resumo

29. Harris VM, Sharma R, Cavett J, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome. Clin Immunol. 2016 Jul;168:25-29.Texto completo  Resumo

30. Scofield RH, Kurien BT, Reichlin M. Immunologically restricted and inhibitory anti-Ro in monozygotic twins. Lupus. 1997;6(4):395-8. Resumo

31. Bolstad AI, Haga HJ, Wassmuth R, et al. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol. 2000 Sep;27(9):2264-6. Resumo

32. Sumida T, Azuma N, Moriyama M, et al. Clinical practice guideline for Sjögren's syndrome 2017. Mod Rheumatol. 2018 May;28(3):383-408. Resumo

33. Romão VC, Talarico R, Scirè CA, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(suppl 1):e000789.Texto completo  Resumo

34. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis. 1994 Oct;53(10):637-47.Texto completo  Resumo

35. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017 Jan;69(1):35-45.Texto completo  Resumo

36. Foulks GN, Forstot SL, Donshik PC, et al. The Sjogren's Syndrome Foundation clinical practice guidelines. Ocular management in Sjogren's patients. 2015 [internet publication].Texto completo

37. Venables PJ. Sjogren's syndrome. Best Pract Res Clin Rheumatol. 2004 Jun;18(3):313-29. Resumo

38. Fox PC, Brennan M, Pillemer S, et al. Sjogren's syndrome: a model for dental care in the 21st century. J Am Dent Assoc. 1998 Jun;129(6):719-28. Resumo

39. Barendregt PJ, Visser MR, Smets EM, et al. Fatigue in primary Sjogren's syndrome. Ann Rheum Dis. 1998 May;57(5):291-5.Texto completo  Resumo

40. Gudbjornsson B, Broman JE, Hetta J, et al. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol. 1993 Dec;32(12):1072-6. Resumo

41. Rozis M, Vlamis J, Vasiliadis E, et al. Musculoskeletal manifestations in Sjogren's syndrome: an orthopedic point of view. J Clin Med. 2021 Apr 8;10(8):1574.Texto completo  Resumo

42. Lei L, Morgan S, Ntatsaki E, et al. Comparative assessment of hand joint ultrasound findings in symptomatic patients with systemic lupus erythematosus and Sjögren's syndrome: a pilot study. Ultrasound Med Biol. 2019 Feb;45(2):452-60. Resumo

43. Colafrancesco S, Priori R, Gattamelata A, et al. Myositis in primary Sjögren's syndrome: data from a multicentre cohort. Clin Exp Rheumatol. 2015 Jul-Aug;33(4):457-64. Resumo

44. Ramos-Casals M, Anaya JM, García-Carrasco M, et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore). 2004 Mar;83(2):96-106.Texto completo  Resumo

45. Kittridge A, Routhouska SB, Korman NJ. Dermatologic manifestations of Sjögren syndrome. J Cutan Med Surg. 2011 Jan-Feb;15(1):8-14. Resumo

46. Chapnick SL, Merkel PA. Skin ulcers in a patient with Sjögren's syndrome. Arthritis Care Res (Hoboken). 2010 Jul;62(7):1040-6.Texto completo  Resumo

47. Guellec D, Cornec-Le Gall E, Groh M, et al. ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev. 2015 Aug;14(8):742-50. Resumo

48. Lu MC, Yin WY, Tsai TY, et al. Increased risk of primary Sjögren's syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan. PLoS One. 2013;8(10):e77210.Texto completo  Resumo

49. Ramos-Casals M, García-Carrasco M, Cervera R, et al. Thyroid disease in primary Sjögren syndrome. Study in a series of 160 patients. Medicine (Baltimore). 2000 Mar;79(2):103-8.Texto completo  Resumo

50. Flament T, Bigot A, Chaigne B, et al. Pulmonary manifestations of Sjögren's syndrome. Eur Respir Rev. 2016 Jun;25(140):110-23.Texto completo  Resumo

51. Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012 Jan;46(1):25-30.Texto completo  Resumo

52. Maury CP, Törnroth T, Teppo AM. Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum. 1985 Apr;28(4):388-94.Texto completo  Resumo

53. Melchor S, Sánchez-Piedra C, Fernández Castro M, et al. Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry. Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):110-115. Resumo

54. Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjögren's syndrome. Br J Rheumatol. 1994 Aug;33(8):745-8.Texto completo  Resumo

55. Montaño-Loza AJ, Crispín-Acuña JC, Remes-Troche JM, et al. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren's syndrome. Ann Hepatol. 2007 Jul-Sep;6(3):150-5. Resumo

56. François H, Mariette X. Renal involvement in primary Sjögren syndrome. Nat Rev Nephrol. 2016 Feb;12(2):82-93. Resumo

57. François H, Mariette X. Renal involvement in Sjögren's syndrome [in French]. Nephrol Ther. 2020 Dec;16(7):440-52. Resumo

58. Leppilahti M, Tammela TL, Huhtala H, et al. Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland. Am J Med. 2003 Jul;115(1):62-5. Resumo

59. Lehrer S, Bogursky E, Yemini M, et al. Gynecologic manifestations of Sjögren's syndrome. Am J Obstet Gynecol. 1994 Mar;170(3):835-7. Resumo

60. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004 Sep;83(5):280-91.Texto completo  Resumo

61. Scofield AK, Radfar L, Ice JA, et al. Relation of sensory peripheral neuropathy in Sjogren syndrome to anti-Ro/SSA. J Clin Rheumatol. 2012 Sep;18(6):290-3. Resumo

62. Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):798-802. Resumo

63. Napeñas JJ, Rouleau TS. Oral complications of Sjogren's syndrome. Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):55-62. Resumo

64. Al-Hashimi I, Khuder S, Haghighat N, et al. Frequency and predictive value of the clinical manifestations in Sjogren's syndrome. J Oral Pathol Med. 2001 Jan;30(1):1-6. Resumo

65. Soto-Rojas AE, Kraus A. The oral side of Sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res. 2002 Mar-Apr;33(2):95-106. Resumo

66. Klasser GD, Balasubramaniam R, Epstein J. Topical review-connective tissue diseases: orofacial manifestations including pain. J Orofac Pain. 2007 Summer;21(3):171-84. Resumo

67. Liao MT, Chien WC, Wang JC, et al. Increased risk of bisphosphonate-related osteonecrosis of the jaw in patients with Sjögren's syndrome: nationwide population-based cohort study. BMJ Open. 2019 Feb 13;9(2):e024655.Texto completo  Resumo

68. Seneff S, Swanson NL, Koenig G, et al. Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins. Dis Markers. 2016 Sep 28;2016:8376979.Texto completo  Resumo

69. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8.Texto completo  Resumo

70. Colella G, Cannavale R, Vicidomini A, et al. Salivary gland biopsy: a comprehensive review of techniques and related complications. Rheumatology (Oxford). 2010 Nov;49(11):2117-21. Resumo

71. Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren’s syndrome - a place in the diagnostic criteria? Rheum Dis Clin North Am. 2016 Aug;42(3):501-17. Resumo

72. Zhang X, Zhang S, He J, et al. Ultrasonographic evaluation of major salivary glands in primary Sjogren's syndrome: comparison of two scoring systems. Rheumatology (Oxford). 2015 Sep;54(9):1680-7.Texto completo  Resumo

73. Luciano N, Baldini C, Tarantini G, et al. Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjogren's syndrome from undifferentiated connective tissue diseases. Rheumatology (Oxford). 2015 Dec;54(12):2198-204. Resumo

74. Zabotti A, Zandonella Callegher S, Tullio A, et al. Salivary gland ultrasonography in Sjögren's syndrome: a European multicenter reliability exercise for the HarmonicSS project. Front Med (Lausanne). 2020;7:581248.Texto completo  Resumo

75. Newbrun E. Current treatment modalities of oral problems of patients with Sjogren's syndrome: caries prevention. Adv Dent Res. 1996 Apr;10(1):29-34. Resumo

76. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren's syndrome. BMC Clin Pathol. 2005 Mar 1;5(1):4.Texto completo  Resumo

77. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004 Jun 28;164(12):1275-84.Texto completo  Resumo

78. Tucci M, Quatraro C, Silvestris F. Sjogren's syndrome: an autoimmune disorder with otolaryngological involvement. Acta Otorhinolaryngol Ital. 2005 Jun;25(3):139-44.Texto completo  Resumo

79. Segerberg-Konttinen M, Konttinen YT, Bergroth V. Focus score in the diagnosis of Sjogren's syndrome. Scand J Rheumatol Suppl. 1986;61:47-51. Resumo

80. Whitcher JP, Shiboski CH, Shiboski SC, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry. Am J Ophthalmol. 2010 Mar;149(3):405-15. Resumo

81. Daniels TE, Benn DK. Is sialography effective in diagnosing the salivary component of Sjogren's syndrome? Adv Dent Res. 1996 Apr;10(1):25-8. Resumo

82. Nicholson DA. Contrast media in sialography: a comparison of Lipiodol Ultra Fluid and Urografin 290. Clin Radiol 1990 Dec;42(6):423-6. Resumo

83. Hernández-Molina G, Avila-Casado C, Nuñez-Alvarez C, et al. Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjogren's syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology (Oxford). 2015 Mar;54(3):441-8. Resumo

84. Shiboski SC, Shiboski CH, Criswell L, et al; Sjogren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87.Texto completo  Resumo

85. Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjogren syndrome: a systematic review. JAMA. 2010 Jul 28;304(4):452-60.Texto completo  Resumo

86. Kalk WW, Mansour K, Vissink A, et al. Oral and ocular manifestations in Sjogren's syndrome. J Rheumatol. 2002 May;29(5):924-30. Resumo

87. Vivino FB, Zero D, Brennan M, et al. Sjogren's Syndrome Foundation's clinical practice guidelines. Oral management: caries prevention in Sjogren's patients. 2015 [internet publication].Texto completo

88. Samarkos M, Moutsopoulos HM. Recent advances in the management of ocular complications of Sjogren's syndrome. Curr Allergy Asthma Rep. 2005 Jul;5(4):327-32. Resumo

89. Jacobi C, Cursiefen C. Ophthalmological complications in Sjogren's syndrome [in German]. Z Rheumatol. 2010 Feb;69(1):32-40. Resumo

90. Byun YJ, Kim TI, Kwon SM, et al. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye. Cornea. 2012 May;31(5):509-13. Resumo

91. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology. 1999 Apr;106(4):811-6.Texto completo  Resumo

92. Hong S, Kim T, Chung SH, et al. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome. J Ocul Pharmacol Ther. 2007 Feb;23(1):78-82. Resumo

93. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Punctal occlusion in Sjogren's syndrome needs clarification. Nat Rev Rheumatol. 2012;8:752. Resumo

94. Zandbelt MM, van den Hoogen FH, de Wilde PC, et al. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjogren's syndrome. Ann Rheum Dis. 2001 May;60(5):511-3. Resumo

95. Mavragani CP, Moutsopoulos HM. Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol. 2007 Jun;32(3):284-91. Resumo

96. Mavragani CP, Moutsopoulos HM. Immunosuppression and immunomodulation in Sjogren’s syndrome - what is the evidence? Does it relieve the sicca symptoms? Aktuelle Rheumatologie. 2005;30:66-70.

97. Fox PC, Datiles M, Atkinson JC, et al. Prednisone and piroxicam for treatment of primary Sjogren’s syndrome. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):149-56. Resumo

98. Akpek EK, Lindsley KB, Adyanthaya RS, et al. Treatment of Sjogren's syndrome-associated dry eye: an evidence-based review. Ophthalmology. 2011 Jul;118(7):1242-52. Resumo

99. Gündüz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren’s syndrome. Acta Ophthalmol (Copenh). 1994 Aug;72(4):438-42. Resumo

100. Fan WS, Hung HL, Liao HP, et al. Topical cyclosporine therapy for keratoconjunctivitis sicca in Sjogren’s syndrome. Tzu Chi Med J. 2003;15:85-89.

101. Drosos AA, Skopouli FN, Galanopoulu VK, et al. Cyclosporin A therapy in patients with primary Sjogren's syndrome: results at one year. Scand J Rheumatol Suppl. 1986;61:246-9. Resumo

102. Drosos AA, Skopouli FN, Costopoulos JS, et al. Cyclosporin A (CyA) in primary Sjogren’s syndrome: a double blind study. Ann Rheum Dis. 1986 Sep;45(9):732-5.Texto completo  Resumo

103. Skopouli FN, Jagiello P, Tsifetaki N, et al. Methotrexate in primary Sjogren's syndrome. Clin Exp Rheumatol. 1996 Sep-Oct;14(5):555-8. Resumo

104. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. Br J Rheumatol. 1995 Apr;34(4):326-33. Resumo

105. Thanou-Stavraki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum. 2008 Apr;37(5):273-92. Resumo

106. Touma Z, Sayad J, Arayssi T. Successful treatment of Sjogren's syndrome with rituximab. Scand J Rheumatol. 2006 Jul-Aug;35(4):323-5. Resumo

107. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014 Feb 18;160(4):233-42. Resumo

108. Gottenberg JE, Ravaud P, Puéchal X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA. 2014 Jul 16;312(3):249-58.Texto completo  Resumo

109. Carsons SE, Vivino FB, Parke A, et al. Treatment guidelines for rheumatologic manifestations of Sjögren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain. Arthritis Care Res (Hoboken). 2017 Apr;69(4):517-27.Texto completo  Resumo

110. Scofield RH. Vasculitis in Sjogren's Syndrome. Curr Rheumatol Rep. 2011 Dec;13(6):482-8. Resumo

111. Wakasugi D, Kato T, Gono T, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod Rheumatol. 2009;19(4):437-40. Resumo

112. Rist S, Sellam J, Hachulla E, et al. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjogren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken). 2011 Sep;63(9):1339-44. Resumo

113. Morozumi S, Kawagashira Y, Iijima M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci. 2009 Apr 15;279(1-2):57-61. Resumo

114. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jan;97(1):28-46. Resumo

115. Pan Q, Angelina A, Marrone M, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2017;(2):CD009327.Texto completo  Resumo

116. López-García JS, García-Lozano I, Rivas L, et al. Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study. Acta Ophthalmol. 2014 Feb;92(1):e22-9.Texto completo  Resumo

117. Kim BH, Kim MH, Kang SH, et al. Optimizing acupuncture treatment for dry eye syndrome: a systematic review. BMC Complement Altern Med. 2018 May 3;18(1):145.Texto completo  Resumo

118. Vivino FB, Al-Hashimi I, Khan Z, et al; P92-01 Study Group. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med. 1999 Jan 25;159(2):174-81.Texto completo  Resumo

119. Harboe E, Tjensvoll AB, Maroni S, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Ann Rheum Dis. 2009 Oct;68(10):1541-6. Resumo

120. Westhoff G, Dörner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study. Rheumatology (Oxford). 2012 Feb;51(2):262-9.Texto completo  Resumo

121. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol. 2007 Jun;32(3):265-74. Resumo

122. Fox RI. Sjogren's syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs. 2000 Sep;9(9):2007-16. Resumo

123. Mariette X. Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis. 2001 Nov;60(11):1007-10.Texto completo  Resumo

124. Bartoloni E, Baldini C, Schillaci G, et al. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. J Intern Med. 2015 Aug;278(2):185-92.Texto completo  Resumo

125. Yong WC, Sanguankeo A, Upala S. Association between primary Sjögren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):190-7. Resumo

126. Berardicurti O, Ruscitti P, Cipriani P, et al. Cardiovascular disease in primary Sjögren's syndrome. Rev Recent Clin Trials. 2018;13(3):164-9. Resumo

127. Mofors J, Holmqvist M, Westermark L, et al. Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome. J Intern Med. 2019 Oct;286(4):458-68.Texto completo  Resumo